Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the effects of intranasal peptide T and placebo in the treatment of painful
peripheral neuropathy associated with human immunodeficiency virus (HIV) infection.